Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Liabilities and Shareholders Equity (2023 - 2025)

Cannabis Bioscience International Holdings' Liabilities and Shareholders Equity history spans 3 years, with the latest figure at $22131.0 for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 36.34% year-over-year to $22131.0; the TTM value through Nov 2025 reached $87839.0, down 62.17%, while the annual FY2025 figure was $31880.0, 44.23% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $22131.0 at Cannabis Bioscience International Holdings, up from $18942.0 in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $101842.0 in Q4 2023 and bottomed at $14886.0 in Q1 2025.
  • The 3-year median for Liabilities and Shareholders Equity is $39074.0 (2023), against an average of $46524.5.
  • The largest annual shift saw Liabilities and Shareholders Equity skyrocketed 31.76% in 2024 before it tumbled 84.16% in 2025.
  • A 3-year view of Liabilities and Shareholders Equity shows it stood at $101842.0 in 2023, then tumbled by 65.86% to $34766.0 in 2024, then tumbled by 36.34% to $22131.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Liabilities and Shareholders Equity are $22131.0 (Q4 2025), $18942.0 (Q3 2025), and $31880.0 (Q2 2025).